LCM Capital Management Inc

Position in VRTX — Vertex Pharmaceuticals Inc / Ma

CIK 1861752 CHICAGO, IL

Position in VRTX

as of Jun 30, 2026 · filed Jul 30, 2026 Compact

Position Value

$594,089

+$76,996 QoQ

Shares Held

1,196

+3.3% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.32%

of 13F equity value

Holder Rank

#1,012

of 1,735 holders

Holding Since

Mar 2023

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

LCM Capital Management Inc holds $1,381,075 across 6 Biotechnology names. VRTX ranks #1 (43.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma This page	1,196	$594,089
2	REGN	Regeneron Pharmaceuticals, Inc.	603	$375,994
3	INCY	Incyte Corp	2,158	$244,630
4	NUVB	Nuvation Bio Inc.	15,000	$85,200
5	RXRX	Recursion Pharmaceuticals, Inc.	15,000	$55,050
6	GERN	Geron Corp	20,400	$26,112

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$594,089	1,196	+3.3%	Shares	Sole	2026-07-30
2026-03-31	$517,093	1,158	+2.0%	Shares	Sole	2026-04-21
2025-12-31	$514,563	1,135	-0.9%	Shares	Sole	2026-01-29
2025-09-30	$448,427	1,145	-0.3%	Shares	Sole	2025-10-28
2025-06-30	$511,089	1,148	+0.3%	Shares	Sole	2025-07-14
2025-03-31	$554,634	1,144	+6.6%	Shares	Sole	2025-05-09
2024-12-31	$432,097	1,073	+1.8%	Shares	Sole	2025-01-27
2024-09-30	$490,194	1,054	+5.8%	Shares	Sole	2024-10-28
2024-06-30	$466,845	996	+6.0%	Shares	Sole	2024-08-01
2024-03-31	$392,929	940	+1.5%	Shares	Sole	2024-05-06
2023-12-31	$376,780	926	+1.8%	Shares	Sole	2024-02-05
2023-09-30	$316,443	910	+14.2%	Shares	Sole	2023-11-07
2023-06-30	$280,472	797	+5.1%	Shares	Sole	2023-08-11
2023-03-31	$238,823	758	—	Shares	Sole	2023-05-01
No filing history on record for this holder in this stock.